Format
Sort by
Items per page

Send to

Choose Destination

Best matches for BBA-REV CANCER[ta]:

Cancer nanomedicine: progress, challenges and opportunities. Shi J et al. Nat Rev Cancer. (2017)

Cell cycle proteins as promising targets in cancer therapy. Otto T et al. Nat Rev Cancer. (2017)

Drugging the 'undruggable' cancer targets. Dang CV et al. Nat Rev Cancer. (2017)

Search results

Items: 1 to 20 of 53325

  • The following term was not found in PubMed: BBA-REV.
1.

Phenotype plasticity as enabler of melanoma progression and therapy resistance.

Arozarena I, Wellbrock C.

Nat Rev Cancer. 2019 Jun 17. doi: 10.1038/s41568-019-0154-4. [Epub ahead of print] Review.

PMID:
31209265
2.

γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer.

Silva-Santos B, Mensurado S, Coffelt SB.

Nat Rev Cancer. 2019 Jun 17. doi: 10.1038/s41568-019-0153-5. [Epub ahead of print] Review.

PMID:
31209264
3.

Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.

Berlow NE, Rikhi R, Geltzeiler M, Abraham J, Svalina MN, Davis LE, Wise E, Mancini M, Noujaim J, Mansoor A, Quist MJ, Matlock KL, Goros MW, Hernandez BS, Doung YC, Thway K, Tsukahara T, Nishio J, Huang ET, Airhart S, Bult CJ, Gandour-Edwards R, Maki RG, Jones RL, Michalek JE, Milovancev M, Ghosh S, Pal R, Keller C.

BMC Cancer. 2019 Jun 17;19(1):593. doi: 10.1186/s12885-019-5681-6.

PMID:
31208434
4.

A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC.

Shang X, Liu J, Li Z, Lin J, Wang H.

BMC Cancer. 2019 Jun 17;19(1):591. doi: 10.1186/s12885-019-5797-8.

PMID:
31208403
5.

Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.

Gebrehiwot AG, Melka DS, Kassaye YM, Gemechu T, Lako W, Hinou H, Nishimura SI.

BMC Cancer. 2019 Jun 17;19(1):588. doi: 10.1186/s12885-019-5817-8.

PMID:
31208374
6.

A new mouse model to study the role of ectopic Nanos3 expression in cancer.

Andries V, De Keuckelaere E, Staes K, Hochepied T, Taminau J, Lemeire K, Birembaut P, Berx G, van Roy F.

BMC Cancer. 2019 Jun 17;19(1):598. doi: 10.1186/s12885-019-5807-x.

PMID:
31208373
7.

Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells.

Amrutkar M, Aasrum M, Verbeke CS, Gladhaug IP.

BMC Cancer. 2019 Jun 17;19(1):596. doi: 10.1186/s12885-019-5803-1.

PMID:
31208372
8.

Blocking podoplanin suppresses growth and pulmonary metastasis of human malignant melanoma.

Xu M, Wang X, Pan Y, Zhao X, Yan B, Ruan C, Xia L, Zhao Y.

BMC Cancer. 2019 Jun 17;19(1):599. doi: 10.1186/s12885-019-5808-9.

PMID:
31208371
9.

EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer.

Fang W, Huang Y, Hong S, Zhang Z, Wang M, Gan J, Wang W, Guo H, Wang K, Zhang L.

BMC Cancer. 2019 Jun 17;19(1):595. doi: 10.1186/s12885-019-5820-0.

PMID:
31208370
10.

The expression of S100A8/S100A9 is inducible and regulated by the Hippo/YAP pathway in squamous cell carcinomas.

Li Y, Kong F, Jin C, Hu E, Shao Q, Liu J, He D, Xiao X.

BMC Cancer. 2019 Jun 17;19(1):597. doi: 10.1186/s12885-019-5784-0.

PMID:
31208368
11.

Computational analysis of receptor tyrosine kinase inhibitors and cancer metabolism: implications for treatment and discovery of potential therapeutic signatures.

Li J, Halfter K, Zhang M, Saad C, Xu K, Bauer B, Huang Y, Shi L, Mansmann UR.

BMC Cancer. 2019 Jun 17;19(1):600. doi: 10.1186/s12885-019-5804-0.

PMID:
31208363
12.

Molecular genetic characterization reveals linear tumor evolution in a pulmonary sarcomatoid carcinomas patient with a novel PHF20-NTRK1 fusion: a case report.

Ge J, Yao B, Huang J, Wu X, Bao H, Ou Q, Shao YW, Chen J.

BMC Cancer. 2019 Jun 17;19(1):592. doi: 10.1186/s12885-019-5780-4.

PMID:
31208361
13.
14.

Multiple secondary cauda equina non-Hodgkin's lymphoma: a case report and literature review.

Ban Y, Jing Z, Zou J.

BMC Cancer. 2019 Jun 17;19(1):594. doi: 10.1186/s12885-019-5800-4.

PMID:
31208357
15.

Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response.

Resende U, Cabello C, Ramalho SOB, Zeferino LC.

BMC Cancer. 2019 Jun 17;19(1):601. doi: 10.1186/s12885-019-5812-0.

PMID:
31208353
16.

Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis.

Xu J, Long Y, Ni L, Yuan X, Yu N, Wu R, Tao J, Zhang Y.

BMC Cancer. 2019 Jun 17;19(1):589. doi: 10.1186/s12885-019-5791-1.

PMID:
31208348
17.

Glioma incidence and survival variations by county-level socioeconomic measures.

Cote DJ, Ostrom QT, Gittleman H, Duncan KR, CreveCoeur TS, Kruchko C, Smith TR, Stampfer MJ, Barnholtz-Sloan JS.

Cancer. 2019 Jun 17. doi: 10.1002/cncr.32328. [Epub ahead of print]

PMID:
31206646
18.

Explicit prognostic disclosure to Asian women with breast cancer: A randomized, scripted video-vignette study (J-SUPPORT1601).

Mori M, Fujimori M, van Vliet LM, Yamaguchi T, Shimizu C, Kinoshita T, Morishita-Kawahara M, Inoue A, Inoguchi H, Matsuoka Y, Bruera E, Morita T, Uchitomi Y.

Cancer. 2019 Jun 17. doi: 10.1002/cncr.32327. [Epub ahead of print]

PMID:
31206639
19.

Risk of breast cancer by prior screening results among women participating in BreastScreen Norway.

Lilleborge M, Falk RS, Russnes H, Sauer T, Ursin G, Hofvind S.

Cancer. 2019 Jun 17. doi: 10.1002/cncr.32330. [Epub ahead of print]

PMID:
31206638
20.

Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.

Patel SA, Qureshi MM, Dyer MA, Jalisi S, Grillone G, Truong MT.

Cancer. 2019 Jun 17. doi: 10.1002/cncr.32292. [Epub ahead of print]

PMID:
31206637

Supplemental Content

Loading ...
Support Center